[1] FAYAZ S,DEMIAN G A,EL-SHERIFY M,et al.Triple negative breast cancer:10-year survival update of the applied treatment strategy in Kuwait[J].Gulf J Oncolog,2019,1(29):53-59.
[2] 严瑞明,王薇.肿瘤相关巨噬细胞研究进展[J].西部医学,2018,30(9):1387-1389,1396.
[3] 石文龙,巫姜,孟庆杰,等.miR-34c-3p与M2型肿瘤相关巨噬细胞在三阴性乳腺癌中的表达及意义[J].现代肿瘤医学,2019,27(1):4-8.
[4] LAN L,WANG Y,PAN Z,et al.Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway[J].Oncol Lett,2019(1):676-682.
[5] 冯刚,李良平,樊友本,等.miR-34a对乳腺癌细胞增殖与侵袭的影响[J].重庆医学,2019,48(2):207-211.
[6] 马宁,杨艳芳,王世霞,等.三阴性特殊类型乳腺癌患者的临床病理特征及预后[J].肿瘤,2019(3):196-203.
[7] 余长艳,甄丽娜,李洪滨,等.肿瘤相关巨噬细胞在三阴性乳腺癌中的表达与临床病理因素及预后关系的研究[J].实用肿瘤学杂志,2017,31(1):1-6.
[8] 邱兴堤,吴安玥,邱丽华.外泌体在肿瘤与肿瘤相关巨噬细胞相互关系中的作用[J].上海医学,2019,22(2):121-123.
[9] OHASHI R,YANAGIHARA K,NAMIMATSU S,et al.Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotype[J].Pathol Res Pract,2018,214(2):253-258.
[10] PIAO Y J,KIM H S,HWANG E H,et al.Breast cancer cell-derived exosomes and macrophage polarization are associated with lymph node metastasis[J].Oncotarget,2017,9(7):7398-7410.
[11] 迟婷,姜晓燕.乳腺癌组织中miR-34a与VEGF的关系及临床意义[J].中国普通外科杂志,2016,25(5):680-685.
[12] 刘棣,张寅斌,闫婉君,等.miRNA-34a抑制乳腺癌细胞MCF-7、MDA-MB-231的增殖与侵袭[J].现代肿瘤医学,2018,26(14):2156-2159.
[13] 王振威,肖刚,刘威,等.miRNA-34a及XIAP在不同基因分型乳腺癌中的表达及意义[J].癌症进展,2018,16(11):1411-1415. |